IL12 Gene Polymorphism in Association with Hepatocellular Carcinoma in HCV-infected Egyptian Patients

References

• Chen X, Han S, Wang S, et al. (2009). Interactions of IL-12A and IL-12B polymorphisms on the risk of cervical cancer in Chinese women. Clin Cancer Res, 15, 400–405.
   PubMed Web of Science ®Google Scholar
• Colombo MP, Trinchieri G. (2002). Interleukin-12 in anti-tumor immunity and immunotherapy. Cytokine Growth Factor Rev, 13, 155–168.
   PubMed Web of Science ®Google Scholar
• Donato F, Tagger A, Chiesa R, et al. (1997). Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma: a case-control study in Italy. Brescia HCC Study. Hepatology, 26, 579–584.
   PubMed Web of Science ®Google Scholar
• Egyptian Ministry of Health. (2007). Egyptian Ministry of Health Annual Report. Available at http://www.mohp.gov.eg/main (accessed 2 May 2015).
   Google Scholar
• El-Nady GM, Ling R, Harrison TJ. (2003). Gene expression in HCV-associated hepatocellular carcinoma–upregulation of a gene encoding a protein related to the ubiquitin-conjugating enzyme. Liver Int, 23, 329–337.
   PubMed Web of Science ®Google Scholar
• El-Zanaty F, Way A. (2009). Egypt Demographic and Health Survey 2008. Egypt: Ministry of Health. Cairo: El-Zanaty and Associates, and Macro International.
   Google Scholar
• El-Zayadi AR, Badran HM, Barakat EM, et al. (2005). Hepatocellular carcinoma in Egypt: a single center study over a decade. World J Gastroenterol, 11, 5193–5198.
   PubMed Web of Science ®Google Scholar
• Farooqi ZR, Afzal MS, Tahir S, et al. (2011). Interleukin-12 P40 (IL-12 B) Taq-1 Polymorphism association in pharmacogenomics of HCV genotype 3a infection from Pakistani population. NUST Center of Virology and Immunology (NCVI), National University of Sciences and Technology, Islamabad, Pakistan. International Conference on Environmental, Biomedical and Biotechnology IPCBEE vol. 16, IACSIT Press, Singapore.
   Google Scholar
• Grzegorzewska AE, Wobszal PM, Mostowska A, and Jagodziński PP. (2012). Antibodies to hepatitis B virus surface antigen and interleukin 12 and interleukin 18 gene polymorphisms in hemodialysis patients. BMC Nephrol, 13, 75.
   PubMed Web of Science ®Google Scholar
• Houldsworth A, Metzner M, Rossol S, et al. (2005). Polymorphisms in the IL-12B gene and outcome of HCV infection. Interferon Cytokine Res, 25(5), 271–276.
   PubMed Web of Science ®Google Scholar
• Ibrahim AS, Khaled HM, Mikhail NN, et al. (2014). Cancer incidence in Egypt: results of the national population-based cancer registry program. J Cancer Epidemiol, 2014, 437971.
   PubMedGoogle Scholar
• Liang TJ, Heller T. (2004). Pathogenesis of hepatitis C-associated hepatocellular carcinoma. Gastroenterol, 127, S62–S71.
   PubMed Web of Science ®Google Scholar
• Liu L, Xu Y, Liu Z, et al. (2011). IL12 polymorphisms, HBV infection and risk of hepatocellular carcinoma in a high-risk Chinese population. J Cancer, 128, 1692–1696.
   Web of Science ®Google Scholar
• Mohamoud YA, Mumtaz GR, Riome S, et al. (2013). The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis. BMC Infect Dis, 13, 288.
   PubMed Web of Science ®Google Scholar
• Nieters A, Yuan JM, Sun CL, et al. (2005). Effect of cytokine genotypes on the hepatitis B virus-hepatocellular carcinoma association. Cancer, 103(4), 740–748.
   Google Scholar
• Peng Q, Li S, Lao X, et al. (2014). Interleukin-12B+1188A/C polymorphism contributes to increased hepatocellular carcinoma susceptibility: evidence from a meta-analysis. Clin Res Hepatol Gastroenterol, 38(6), 735–743.
   PubMed Web of Science ®Google Scholar
• Shaw-Stiffel TA. (2000). Chronic hepatitis. In: Mandell GL, Bennett JE, Dolin R, et al., eds. Principles and Practice of Infectious Diseases (5th edition). New York: Churchill Livingstone, 1297–1321.
   Google Scholar
• Tan A, Gao Y, Yao Z, et al. (2015). Genetic variants in IL12 influence both hepatitis B virus clearance and HBV-related hepatocellular carcinoma development in a Chinese male population. Tumour Biol, 37(5), 6343–6348.
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Agha S, Saudy N, et al. (2004). Exponential spread of hepatitis C virus genotype 4a in Egypt. J Mol Evol, 58, 191–195.
   PubMed Web of Science ®Google Scholar
• Trinchieri G. (2003). Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol, 3, 133–146.
   PubMed Web of Science ®Google Scholar
• World Health Organization, A63/15. (2010). Available at http://apps.who.int/gb/ebwha/pdf_files/WHA63/A63_15-en.pdf. Viral hepatitis. Sixty third world health assembly Provisional agenda item 11.12.
   Google Scholar
• Yates SC, Hafez M, Beld M, et al. (1999). Hepatocellular carcinoma in Egyptians with and without a history of hepatitis B virus infection: association with hepatitis C virus (HCV) infection but not with (HCV) RNA level. Am J Trop Med Hyg, 60, 714–720.
   PubMed Web of Science ®Google Scholar
• Yeh CT, Chen TC, Chang ML, et al. (2007). Identification of NV-F virus DNA in hepatocellular carcinoma. J Med Virol, 79, 92–96.
   PubMed Web of Science ®Google Scholar
• Yin L, Zhu W, Wei L, et al. (2004). Association of interleukin-12 p40 gene 3’-untranslated region polymorphism and outcome of HCV infection. World J Gastroenterol, 10 (16), 2330–2333.
   Google Scholar
• Youssef SS, Abd El Aal AM, Nasr AS, et al. (2013). Interleukin-12B gene polymorphism frequencies in Egyptians and sex-related susceptibility to hepatitis C infection. Interferon Cytokine Res, 33 (8), 415–419.
   Google Scholar
• Yu L, Sun L, Jiang YF, et al. (2012). Interactions between CYP1A1 polymorphisms and cigarette smoking are associated with the risk of hepatocellular carcinoma: evidence from epidemiological studies. Mol Biol Rep, 39, 6641–6646.
   PubMed Web of Science ®Google Scholar
• Yuzhalin AE, Kutikhin AG. (2012). Interleukin-12: clinical usage and molecular markers of cancer susceptibility. Growth Factors, 30(3), 176–191.
   PubMed Web of Science ®Google Scholar